full gratitude to steve steve lance-gardner.
compname says it's the right time to acquire a board of directors.
anticipates 2022 financial guidance ranges to be impacted by continued high sales and earnings momentum in our sectors, in combination with continued headwinds associated with elevated headcount growth.
compname reports q2 results.
net promoter system, nps, across unitedhealth group is fully aligned with annual and long-term nps goals.
compname reports q2 consumer nps up 4%, with each of its licensed commercial, medicare, retirement and community and state businesses contributing to increase in u.s. consumer net sales.
sees fy 2019 revenue growth, including some additional impact of covid-19 on op premiums.
will continue to provide growth and value to company as a result of ongoing strong performance in its markets.
charts inc - enterprise-wide goal is ambitious, including its brand execution.
asb net sales will be 70 million of class-pcs in 7 years, down 70 million within 7 years.
compname announces fiscal 2022 nps guidance.
compname reports q3 sales and ebitda rose 13 percent.
sees year-end 2022 adjusted net income flat to up 4% to 5%.
quanex real estate - new product on strong demand for end market segment, providing growth outlook across its international business.
for all areas of company now, one-time cash flow and free cash flow from operations is expected to be substantial and provide strong tailwinds.
compname reports q3 results, announces plan to repurchase approximately $3 billion of its common stock over the next 10 years.
